Panacea Index Logo

Command Palette

Search for a command to run...

Creatine Supplementation to Improve Sarcopenia in Chronic Liver Disease: Facts and Perspectives.

Nutrients
January 1, 1970
Riccardo Casciola et al. (7 authors)
Journal ArticleReviewHuman Study
Study Details

Study Goal

The researchers aimed to summarize the current evidence for creatine supplementation in advanced chronic liver disease, particularly in sarcopenic cirrhotic patients, and its potential benefits on complications like encephalopathy and fatigue.

Results Summary

The abstract suggests creatine supplementation may have beneficial effects on sarcopenia, fatty liver, encephalopathy, and fatigue in advanced chronic liver disease, though human studies are lacking and evidence is primarily from animal models. Further research is needed to confirm these potential benefits.

Population

Sarcopenic cirrhotic patients and animal models of non-alcoholic fatty liver disease.

Effective Dosage

Not mentioned

Duration

Not mentioned

Interactions

None mentioned

Extracted Claims (8)
InterventionDirectionEndpointPopulationDosageImpactClaim #
Creatine supplementation
increase
performance, strength, and muscular mass
athletes
-
has been one of the most studied and useful ergogenic nutritional support
#1
creatine
increase
several human disease conditions
-
-
has shown beneficial effects
#2
creatine supplementation
increase
chronic liver disease
-
-
potential efficacy
#3
creatine supplementation
increase
fatty liver
animal models of non-alcoholic fatty liver disease
-
bringing beneficial effects
#4
Creatine supplementation
increase
encephalopathy and fatigue
-
-
beneficial effects
#5
Creatine supplementation
increase
sarcopenia
the elderly with and without resistance training
-
has demonstrated effects
#6
Creatine supplementation
increase
this condition
patients with advanced chronic liver disease
-
potential role in improving
#7
Creatine supplementation
increase
chronic liver disease and its complications
-
-
could address several critical points
#8
Abstract

Creatine supplementation has been one of the most studied and useful ergogenic nutritional support for athletes to improve performance, strength, and muscular mass. Over time creatine has shown beneficial effects in several human disease conditions. This review aims to summarise the current evidence for creatine supplementation in advanced chronic liver disease and its complications, primarily in sarcopenic cirrhotic patients, because this condition is known to be associated with poor prognosis and outcomes. Although creatine supplementation in chronic liver disease seems to be barely investigated and not studied in human patients, its potential efficacy on chronic liver disease is indirectly highlighted in animal models of non-alcoholic fatty liver disease, bringing beneficial effects in the fatty liver. Similarly, encephalopathy and fatigue seem to have beneficial effects. Creatine supplementation has demonstrated effects in sarcopenia in the elderly with and without resistance training suggesting a potential role in improving this condition in patients with advanced chronic liver disease. Creatine supplementation could address several critical points of chronic liver disease and its complications. Further studies are needed to support the clinical burden of this hypothesis.

Medical Subject Headings (MeSH)
AnimalsHumansAgedSarcopeniaCreatineLiver DiseasesAthletesDietary SupplementsMuscle, Skeletal
Study Links
Quality Scores
SafetyNot Assessed
Efficacy70/10
Quality60/10
Citation Metrics
Total Citations13
Citations/Year6.5
Relative Citation Ratio3.53
NIH Percentile88.1%
Research Impact Scores
APT Score0.75
Weight Score0.71
Normalized Score0.60
Related Supplements